ARTL logo

Artelo Biosciences, Inc. (ARTL)

Profile

Full Name

Artelo Biosciences, Inc.

Ticker Symbol

NASDAQ: ARTL

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

June 21, 2019

Indexes

Not included

Website

http://www.artelobio.com

Employees

5

Key Details

Price

$15.90(+11.03%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$18.30(+2.87% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $15.90
    ARTL price is $15.90

    30-Day Relative Volume

    0.45
    ARTL 30-day relative volume is 0.45

    Price Performance

    Price Most recent change

    +11.03%
    ARTL price was up +11.03% on Jul 8, 2025

    Price YTD change

    +150%
    ARTL price is up +150% since January 1st

    Price 1-year change

    +100.76%
    ARTL price is up +100.76% year-on-year

    Price 3-year change

    -46.46%
    ARTL price is down -46.46% over the past 3 years

    Price Range

    Price All-time high

    $450.00
    ARTL price is currently -96.47% below its historical high of $450.00

    Price 3-year low

    $4.92
    ARTL price is currently +223.17% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $8.69M
    ARTL market capitalization is $8.69 million

    Market cap 3-year change

    -38.15%
    ARTL market capitalization is down -38.15% over the past 3 years

    Market cap All-time high

    $48.65M
    ARTL market capitalization is currently -82.13% below its historical high of $48.65 million

    Market cap sector rank

    15.66%
    ARTL market capitalization is higher than 15.66% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +1.64%
    ARTL shares outstanding is up +1.64% year-on-year

    Shares Outstanding 3-Year Change

    +15.53%
    ARTL shares outstanding is up +15.53% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.68
    ARTL beta is 0.68

    200-day SMA

    $6.66
    ARTL price is currently +138.59% above its 200-day simple moving average

    50-day SMA

    $6.94
    ARTL price is currently +129.25% above its 50-day simple moving average

    RSI

    73.33
    ARTL 14-day relative strength index is 73.33

    Volume

    0.45
    ARTL 30-day relative volume is 0.45

    ATR

    $2.88
    ARTL average true range is $2.88

    10-day Historical Volatility

    537.30%
    ARTL 10-day historical volatility is 537.30%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    -
    ARTL annual revenue value is unknown

    Revenue Analysts estimate

    -
    ARTL annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    -
    ARTL annual revenue 1-year change is unknown

    Revenue Sector rank

    -
    ARTL annual revenue is unknown

    EPS

    EPS

    -$18.30
    ARTL annual earnings per share is -$18.30

    EPS Analysts estimate

    -$6.48
    ARTL annual earnings per share is currently +182.41% higher than the consensus analysts' forecast

    EPS 1-year change

    +2.87%
    ARTL annual earnings per share is up +2.87% year-on-year

    EPS Sector rank

    8.53%
    ARTL annual earnings per share is higher than 8.53% of companies in Healthcare sector

    Profit

    Gross profit

    -
    ARTL annual gross profit value is unknown

    Gross margin

    -
    ARTL annual gross profit margin value is unknown

    Operating profit

    -$10.11M
    ARTL annual operating income is -$10.11 million

    Operating margin

    -
    ARTL annual operating profit margin value is unknown

    Net income

    -$9.83M
    ARTL annual net profit is -$9.83 million

    Net margin

    -
    ARTL annual net profit margin value is unknown

    Expenses

    Total expenses

    $10.11M
    ARTL annual total expenses is $10.11 million

    Operating expenses

    $10.11M
    ARTL annual total operating expenses is $10.11 million

    Cost of goods sold

    -
    ARTL annual cost of goods sold value is unknown

    Selling, general & administrative expenses

    $4.12M
    ARTL annual SGA is $4.12 million

    Depreciation and amortization

    -
    ARTL annual depreciation & amortization value is unknown

    Interest expense

    -
    ARTL annual interest expense value is unknown

    Income tax

    $0.00
    ARTL annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$10.11M
    ARTL annual earnings before interest & taxes is -$10.11 million

    EBITDA

    -$10.11M
    ARTL annual EBITDA is -$10.11 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $4.70M
    ARTL annual total assets is $4.70 million

    Non current assets

    $2.14M
    ARTL annual long term assets is $2.14 million

    Current assets

    $2.56M
    ARTL annual total current assets is $2.56 million

    Cash and cash equivalents

    $2.34M
    ARTL annual cash & cash equivalents is $2.34 million

    Accounts receivable

    -
    ARTL annual accounts receivable value is unknown

    Inventory

    -
    ARTL annual inventory value is unknown

    Liabilities

    Total liabilities

    $1.84M
    ARTL annual total liabilities is $1.84 million

    Long term liabilities

    $69.00K
    ARTL annual total long term liabilities is $69.00 thousand

    Current liabilities

    $1.77M
    ARTL annual total current liabilities is $1.77 million

    Accounts payable

    $1.68M
    ARTL annual accounts payable is $1.68 million

    Debt

    Total debt

    $104.00K
    ARTL annual total debt is $104.00 thousand

    Total debt 1-year change

    +352.17%
    ARTL annual total debt is up +352.17% year-on-year

    Long term debt

    $69.00K
    ARTL annual long term debt is $69.00 thousand

    Short term debt

    $35.00K
    ARTL annual short term debt is $35.00 thousand

    Equity & Capital

    Shareholders equity

    $2.86M
    ARTL annual stockholders equity is $2.86 million

    Book value

    $2.86M
    ARTL annual book value is $2.86 million

    Retained earnings

    -$50.14M
    ARTL annual retained earnings is -$50.14 million

    Working capital

    $785.00K
    ARTL annual working capital is $785.00 thousand

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$8.35M
    ARTL annual cash flow from operations is -$8.35 million

    Cash from operations 1-year change

    -1.74%
    ARTL annual cash flow from operations is down -1.74% year-on-year

    Cash from investing

    $7.77M
    ARTL annual cash flow from investing activities is $7.77 million

    Cash from investing 1-year change

    +121.53%
    ARTL annual cash flow from investing activities is up +121.53% year-on-year

    Cash from financing

    $112.00K
    ARTL annual cash flow from financing activities is $112.00 thousand

    Cash from financing 1-year change

    -80.25%
    ARTL annual cash flow from financing activities is down -80.25% year-on-year

    CAPEX

    CAPEX

    -
    ARTL annual capital expenditures value is unknown

    CAPEX 1-year change

    -
    ARTL annual capital expenditures 1-year change is unknown

    Free Cash Flow

    Free cash flow

    -$8.35M
    ARTL annual free cash flow is -$8.35 million

    Free cash flow 1-year change

    -1.74%
    ARTL annual free cash flow is down -1.74% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    ARTL annual gross profit margin value is unknown

    Operating margin

    -
    ARTL annual operating profit margin value is unknown

    Net margin

    -
    ARTL annual net profit margin value is unknown

    ROA & ROE

    ROA

    -209.15%
    ARTL annual return on assets is -209.15%

    ROE

    -343.93%
    ARTL annual return on equity is -343.93%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    ARTL price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    ARTL price to earnings ratio is unknown

    PB Ratio

    PB ratio

    13.33
    ARTL price to book ratio is 13.33

    PB ratio Sector rank

    92.41%
    ARTL price to book ratio is higher than 92.41% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    ARTL price to sales ratio value is unknown

    PS ratio Sector rank

    -
    ARTL price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $8.04M
    ARTL enterprise value is $8.04 million

    Enterprise value Sector rank

    20.12%
    ARTL enterprise value is higher than 20.12% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -0.81
    ARTL EV/EBITDA is -0.81

    EV/EBITDA Sector rank

    50.96%
    ARTL EV/EBITDA is higher than 50.96% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    1.44
    ARTL annual current ratio is 1.44

    Quick ratio

    -
    ARTL annual quick ratio value is unknown

    Leverage

    Debt to equity

    0.04
    ARTL annual debt to equity ratio is 0.04

    Interest coverage ratio

    -
    ARTL annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    ARTL piotroski f-score value is unknown

    Altman Z-Score

    -
    ARTL altman z-score value is unknown

    Analyst ratings

    Recent major analysts updates

    Jun 11, 25 D. Boral Capital
    Hold
    Jun 6, 25 D. Boral Capital
    Buy
    Apr 28, 25 D. Boral Capital
    Buy
    Apr 2, 25 D. Boral Capital
    Buy
    Mar 4, 25 HC Wainwright & Co.
    Buy
    Mar 3, 25 D. Boral Capital
    Buy
    Feb 27, 25 D. Boral Capital
    Buy
    Jan 14, 25 D. Boral Capital
    Buy
    Dec 9, 24 HC Wainwright & Co.
    Buy
    Dec 9, 24 D. Boral Capital
    Buy

    Institutional Ownership

    Screeners with ARTL included

    Growing Shares Outstanding
    US stocks
    Best performing stocks last month
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    • What is the ticker symbol for Artelo Biosciences, Inc.?
    • Does Artelo Biosciences, Inc. pay dividends?
    • What sector is Artelo Biosciences, Inc. in?
    • What industry is Artelo Biosciences, Inc. in?
    • What country is Artelo Biosciences, Inc. based in?
    • When did Artelo Biosciences, Inc. go public?
    • Is Artelo Biosciences, Inc. in the S&P 500?
    • Is Artelo Biosciences, Inc. in the NASDAQ 100?
    • Is Artelo Biosciences, Inc. in the Dow Jones?
    • When does Artelo Biosciences, Inc. report earnings?

    What is the ticker symbol for Artelo Biosciences, Inc.?

    The ticker symbol for Artelo Biosciences, Inc. is NASDAQ:ARTL

    Does Artelo Biosciences, Inc. pay dividends?

    No, Artelo Biosciences, Inc. does not pay dividends

    What sector is Artelo Biosciences, Inc. in?

    Artelo Biosciences, Inc. is in the Healthcare sector

    What industry is Artelo Biosciences, Inc. in?

    Artelo Biosciences, Inc. is in the Biotechnology industry

    What country is Artelo Biosciences, Inc. based in?

    Artelo Biosciences, Inc. is headquartered in United States

    When did Artelo Biosciences, Inc. go public?

    Artelo Biosciences, Inc.'s initial public offering (IPO) was on June 21, 2019

    Is Artelo Biosciences, Inc. in the S&P 500?

    No, Artelo Biosciences, Inc. is not included in the S&P 500 index

    Is Artelo Biosciences, Inc. in the NASDAQ 100?

    No, Artelo Biosciences, Inc. is not included in the NASDAQ 100 index

    Is Artelo Biosciences, Inc. in the Dow Jones?

    No, Artelo Biosciences, Inc. is not included in the Dow Jones index

    When does Artelo Biosciences, Inc. report earnings?

    The date for Artelo Biosciences, Inc.'s next earnings report has not been announced yet
    On this page